Hypertrophic cardiomyopathy and pregnancy


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease. Owing to achievements in medicine over recent decades, the number of pregnancies in women with HCM is increasing and will continue to grow in the future. In most women with HCM, pregnancy proceeds without complications; however, during gestation, the risk of adverse cardiovascular events is increased, especially in symptomatic patients who had a high left ventricular outflow tract gradient, heart failure (HF), or arrhythmias before conception. A high functional class of HF prior to pregnancy is statistically significantly associated with an increased risk of cardiovascular complications during pregnancy or in the postpartum period. In this connection, a detailed cardiovascular system assessment in a patient with HCM is needed to determine the potential risks associated with pregnancy and childbirth and to develop an appropriate therapeutic strategy. The review presents the latest national and international guidelines for the diagnosis and management of pregnant women with HCM. It is emphasized that the clinical manifestations and diagnosis of HCM during pregnancy have a number of features and when prescribing medications, it is necessary to take into account their possible negative impact on the health of the mother and fetus.

Full Text

Restricted Access

About the authors

G. A Ignatenko

M. Gorky Donetsk National Medical University

Donetsk, Donetsk People’s Republic/Ukraine

G. G Taradin

M. Gorky Donetsk National Medical University; V.K. Gusak Institute of Emergency and Restorative Surgery

Donetsk, Donetsk People’s Republic/Ukraine

T. E Kugler

M. Gorky Donetsk National Medical University

Email: kugler2@mail.ru
Donetsk, Donetsk People’s Republic/Ukraine

References

  1. Schaufelberger M. Cardiomyopathy and pregnancy. Heart. 2019; 105 (20): 1543-51. doi: 10.1136/heartjnl-2018-313476
  2. Maron B.J., Gardin J.M., Flack J.M. et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995; 92 (4): 785-9. doi: 10.1161/01.cir.92.4.785
  3. Bottega N., Malhame I., Guo L. et al. Secular trends in pregnancy rates, delivery outcomes, and related health care utilization among women with congenital heart disease. Congenit Heart Dis. 2019; 14: 735-44. DOI: 10.1111/ chd.12811
  4. Гипертрофическая кардиомиопатия. Клинические рекомендации. Российское кардиологическое общество. 2020; 151 c. [Электронный ресурс] @@Hypertrophic cardiomyopathy. Clinical guidelines of the Russian cardiology society. 2020;151р. [Electronic resource] (in Russ.)]. URL: https://scardio.ru/content/Guidelines/2020/Clinic_rekom_Kardiomiopatiya.pdf
  5. Диагностика и лечение сердечно-сосудистых заболеваний при беременности 2018. Национальные рекомендации. Российский кардиологический журнал. 2018; 3: 91-134 @@Diagnosis and treatment of cardiovascular diseases during pregnancy 2018. National guidelines. Russian Journal of Cardiology. 2018; 3: 91-134 (in Russ.)]. doi: 10.15829/1560-4071-2018-3-91-134
  6. Regitz-Zagrosek V., Roos-Hesselink J.W., Bauersachs J. et al; ESC Scientific Document Group. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018; 39 (34): 3165-241. DOI: 10.1093/ eurheartj/ehy340
  7. Ommen S.R., Mital S., Burke M.A. et al. 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020; 142 (25): e533-e557. doi: 10.1161/CIR.0000000000000938
  8. Elliott P.M., Anastasakis A., Borger M.A. et al. ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014; 35 (39): 2733-79. doi: 10.1093/eurheartj/ ehu284
  9. van Hagen I.M., Roos-Hesselink J.W. Pregnancy in congenital heart disease: risk prediction and counselling. Heart. 2020; 106: 1853-61. DOI: 10.1136/ heartjnl-2019-314702
  10. Narayanan M., Elkayam U., Naqvi T.Z. Echocardiography in Pregnancy: Part 2. Curr Cardiol Rep. 2016; 18 (9): 90. doi: 10.1111/echo.13242
  11. Ватутин Н.Т., Тарадин Г.Г., Тараторина А.А. и др. Ишемическая болезнь сердца и беременность. Медико-социальные проблемы семьи. 2013; 18 (4): 97-106 [Vatutin N.T., Taradin G.G., Taratorina A.A. et al. Coronary artery disease and pregnancy. Medical and Social Problems of The Family. 2013; 18 (4): 97-106 (in Russ.)].
  12. Горохова C.r., Морозова Т.Е., Аракелянц А.А. и др. Алгоритм эхокардиографического исследования у беременных. Российский кардиологический журнал. 2018; 12: 75-82 @@Gorokhova S.G., Morozova T.E., Arakelyants A.A. et al. Algorithm for echocardiographic research in pregnant women. Russian Journal of Cardiology. 2018; 12: 75-82 (in Russ.)]. doi: 10.15829/1560-4071-2018-12-75-82
  13. van Hagen I.M., Elkayam U., Goland S. et al. Hypertrophic Cardiomyopathy and Pregnancy. In: Cardiac Problems in Pregnancy, 4th Ed. Ed. by U. Elkayam. 2020; 12: р. 167-80.
  14. Avila W.S., Amaral F.M., Ramires J.A. et al. Influence of pregnancy on clinical course and fetal outcome of women with hypertrophic cardiomyopathy. Arq Bras Cardiol. 2007; 88 (4): 480-5. doi: 10.1590/s0066-782x2007000400019
  15. Ватутин Н.Т., Тарадин Г.Г., Марон М.С. Гипертрофическая кардиомиопатия: генетические изменения, патогенез и патофизиология. Российский кардиологический журнал. 2014; 5: 35-42 @@Vatutin N.T., Taradin G.G., Maron M.S. Hypertrophic cardiomyopathy: genetic alterations, pathogenesis and pathophysiology. Russian Journal of Cardiology. 2014; 5: 35-42 (in Russ.)]. doi: 10.15829/1560-4071-2014-5-35-42
  16. Крючкова О.Н., Кучеренко Т.В., Кучеренко Е.А. и др. Гипертрофическая кардиомиопатия, современное состояние проблемы. Особенности ведения беременности и родов. Крымский терапевтический журнал. 2020; 2: 17-20 @@Kryuchkova O.N., ^chernn^ Yu.A., Кucherenko T.V. et al. Hypertrophic cardiomyopathy. The current state of the problem. Features of pregnancy and childbirth. Crimean Therapeutic Journal. 2020; 2: 17-20 (in Russ.)].
  17. McLeod C.J., Ackerman M.J., Nishimura R.A. et al. Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram. J Am Coll Cardiol. 2009; 54 (3): 229-33. doi: 10.1016/j.jacc.2009.02.071
  18. Pandian N.G., Rowin E.J., Gonzalez A.M. et al. Echocardiographic profiles in hypertrophic cardiomyopathy: imaging beyond the septum and systolic anterior motion. Echo Res Pract. 2015; 2 (1): E1-E7. DOI: 10.1530/ ERP-15-0009
  19. Hinojar R., Zamorano J.L., Gonzalez Gomez A. et al. ESC sudden-death risk model in hypertrophic cardiomyopathy: incremental value of quantitative contrast-enhanced CMR in intermediate-risk patients. Clin Cardiol. 2017; 40 (10): 853-60. doi: 10.1002/clc.22735
  20. Игнатенко Г.А., Тарадин Г.Г., Ватутин Н.Т. и др. Фибрилляция предсердий при гипертрофической кардиомиопатии. Архивъ внутренней медицины. 2021; 11 (3): 173-85 @@Ignatenko G.A., Taradin G.G., Vatutin N.T. et al. Atrial fibrillation in hypertrophic cardiomyopathy. The Russian Archives of Internal Medicine. 2021; 11 (3): 173-85 (in Russ.)]. doi: 10.20514/2226-6704-2021-11-3-173-185
  21. Autore C., Conte M.R., Piccininno M. et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002; 40 (10): 1864-9. doi: 10.1016/s0735-1097(02)02495-6
  22. Thaman R., Varnava A., Hamid M.S. et al. Pregnancy related complications in women with hypertrophic cardiomyopathy. Heart. 2003; 89 (7): 752-6. doi: 10.1136/heart.89.7.752
  23. Walker D., Kaur N., Bell R. et al. Hypertrophic obstructive cardiomyopathy and pregnancy: University College London Hospital experience. Minerva Anestesiol. 2007; 73: 485-6.
  24. Schuler P.K., Herrey A., Wade A. et al. Pregnancy outcome and management of women with an implantable cardioverter defibrillator: a single centre experience. Europace. 2012; 14 (12): 1740-5. doi: 10.1093/europace/ eus172
  25. Tanaka H., Kamiya C., Katsuragi S. et al. Cardiovascular events in pregnancy with hypertrophic cardiomyopathy. Circ J. 2014; 78 (10): 2501-6. DOI: 10.1253/ circj.cj-14-0541
  26. Ashikhmina E., Farber M.K., Mizuguchi K.A. Parturients with hypertrophic cardiomyopathy: case series and review of pregnancy outcomes and anesthetic management of labor and delivery. Int J Obstet Anesth. 2015; 24: 344-55. doi: 10.1016/j.ijoa.2015.07.002
  27. Goland S., van Hagen I., Elbaz-Greener G. et al. Pregnancy in women with hypertrophic cardiomyopathy: data from the European Society of Cardiology initiated Registry for Pregnancy and Cardiac disease (ROPAC). Eur Heart J. 2017; 38 (35): 2683-90. doi: 10.1093/eurheartj/ehx189
  28. Billebeau G., Etienne M., Cheikh-Khelifa R. et al. Pregnancy in women with a cardiomyopathy: Outcomes and predictors from a retrospective cohort. Arch Cardiovasc Dis. 2018; 111 (3): 199-209. doi: 10.1016/j.acvd.2017.05.010
  29. Schinkel A.F. Pregnancy in women with hypertrophic cardiomyopathy. Cardiol Rev. 2014; 22 (5): 217-22. doi: 10.1097/CRD.0000000000000010
  30. Assamti M., Bougrine R., Ismaili N. et al. Management and outcome of hypertrophic obstructive cardiomyopathy in pregnant women: a case report. Pan Afr Med J. 2021; 38: 140. doi: 10.11604/pamj.2021.38.140.25699
  31. Мравян C.P., Петрухин В.А., Пронина В.П. и др. Гипертрофическая кардиомиопатия и беременность: «змея в траве». Российский вестник акуше-ра-гинеколога. 2009; 6: 70-4 @@Mravyan S.R., Petrukhin V.A., Pronina V.P. et al. Hypertrophic cardiomyopathy and pregnancy: «Snake in the grass». Russian Bulletin of Obstetrician Gynecologist. 2009; 6: 70-4 (in Russ.)].
  32. Мравян C.P., Петрухин В.А., Пронина В.П. и др. Гипертрофическая кардиомиопатия и беременность: «змея в траве»-2. Российский вестник аку-шера-гинеколога. 2012; 6: 104-7 @@Mravyan S.R., Petrukhin V.A., Pronina V.P. et al. Hypertrophic cardiomyopathy and pregnancy: «snake in the grass»-2. Russian Bulletin of Obstetrician Gynecologist. 2012; 6: 104-7 (in Russ.)].
  33. Колоскова Н.Н., Александрова С.А., Берсенева М.И. и др. Тромбоз левого желудочка у роженицы с гипертрофической обструктивной кардиомиопатией после беременности, индуцированной экстракорпоральным оплодотворением. Креативная кардиология. 2016; 10 (3): 251-7 @@Koloskova N.N., Alexandrova S.A., Berseneva M.I. et al. Left ventricular thrombosis in a woman in labor with hypertrophic obstructive cardiomyopathy after IVF-induced pregnancy. Creative cardiology. 2016; 10 (3): 251-7 (in Russ.)].
  34. Целуйко В.И., Будкова Е.А., Дагхар С. и др. Беременность при обструктивной гипертрофической кардиомиопатии. Медицина неотложных состояний. 2014; 3 (58): 141-7 @@Tseluyko V.I., Budkova E.A., Daghar S. et al. Pregnancy in obstructive hypertrophic cardiomyopathy. Emergency medicine. 2014; 3 (58): 141-7 (in Russ.)].
  35. O’Mahony C., Lambiase P.D., Quarta G. et al. The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy. Heart. 2012; 98 (2): 116-25. doi: 10.1136/hrt.2010.217182
  36. Jaeggi E.T., Carvalho J.S., De Groot E. et al. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation. 2011; 124 (16): 1747-54. doi: 10.1161/CIRCULATIONAHA.111.026120
  37. Tromp C.H., Nanne A.C., Pernet P.J. et al. Electrical cardioversion during pregnancy: safe or not? Neth Heart J. 2011; 19 (3): 134-6. doi: 10.1007/s12471-011-0077-5
  38. Barnes E.J., Eben F., Patterson D. Direct current cardioversion during pregnancy should be performed with facilities available for fetal monitoring and emergency caesarean section. BJOG. 2002; 109 (12): 1406-7.
  39. Tanaka K., Tanaka H., Kamiya C. et al. Beta-blockers and fetal growth restriction in pregnant women with cardiovascular disease. Circ J. 2016; 80 (10): 2221-6. doi: 10.1253/circj.CJ-15-0617

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies